{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:34:23Z","timestamp":1793129663753,"version":"4.5.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2023\/16093-0 2023\/16026-0"],"award-info":[{"award-number":["2023\/16093-0 2023\/16026-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["14030\/2019-4 444090\/2023"],"award-info":[{"award-number":["14030\/2019-4 444090\/2023"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Metamizole (dipyrone) is a widely used analgesic and antipyretic, but its use has been restricted in some countries due to the risk of metamizole-induced agranulocytosis (MIA). This systematic review investigated genetic variants associated with MIA, allele frequencies across ancestry groups, and the drug's legal status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A literature search was conducted across nine databases for studies published up to 08 April 2025. Study selection and data extraction were performed by two independent reviewers. The Withdrawn 2.0 platform was used to assess the global legal status of metamizole, while allele frequencies were obtained from the gnomAD browser (version v4.1.0) and the Allele Frequency Net Database (AFND). Bibliometric analysis was conducted using the VOS viewer software.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, four studies were included in the review. Data related to HLA, NAT2, CYP2C9, CYP2C19, and variants located on chromosome nine were reported; however, statistically significant associations were observed only for variants in chromosome nine and HLA-C*04:01. When comparing countries from different continents with varying metamizole status, the analysis of allele frequencies did not reveal sufficient differences in allele frequencies between countries, which does not justify distinct regulatory frameworks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study highlights the scarcity of data in the literature reporting the association between genetic variants and MIA. Furthermore, there is insufficient evidence to justify the prohibition of metamizole in certain countries based on genetic variants alone. Additional studies are essential to evaluate the prevalence of MIA, better characterize populations, and explore potential genetic associations, particularly concerning the HLA-C*04:01 allele.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Trial Registration<\/jats:title><jats:p><jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42024572038<\/jats:ext-link>, identifier CRD42024572038.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1624044","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T07:22:27Z","timestamp":1758698547000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacogenetics of metamizole-induced agranulocytosis: a systematic review and drug regulation implications"],"prefix":"10.3389","volume":"16","author":[{"given":"Giovana Fernanda Santos","family":"Fidelis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Dagli-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina P.","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefman Efendi","family":"Marzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baharuddin","family":"Baharuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun-Ying","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eder de Carvalho","family":"Pincinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Moriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7247\/jtomc.2014.2136","article-title":"Metamizole related granulocytopenia and agranulocytosis: an analysis of 13 children","volume":"22","author":"Akyay","year":"2015","journal-title":"J. Turgut Ozal Med. Cent."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1177\/147323001003800419","article-title":"Update on the incidence of metamizole sodium-induced blood dyscrasias in Poland","volume":"38","author":"Basak","year":"2010","journal-title":"J. Int. Med. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00228-014-1781-z","article-title":"Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports","volume":"71","author":"Blaser","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e34467","DOI":"10.7759\/cureus.34467","article-title":"A case report on metamizole-induced agranulocytosis: is the benefit worth the risk?","volume":"15","author":"Carvalho","year":"2023","journal-title":"Cureus"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/cpt.2258","article-title":"The uncertainties of metamizole use","volume":"109","author":"Cascorbi","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1111\/bcp.13989","article-title":"Associations of HLA genotypes with antithyroid drug\u2010induced agranulocytosis: a systematic review and meta\u2010analysis of pharmacogenomics studies","volume":"85","author":"Chen","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/cpt.309","article-title":"HLA\u2010B*38:02:01 predicts carbimazole\/methimazole\u2010induced agranulocytosis","volume":"99","author":"Cheung","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fgene.2020.00951","article-title":"High-throughput sequencing to investigate associations between HLA genes and metamizole-induced agranulocytosis","volume":"11","author":"Cismaru","year":"","journal-title":"Front. Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/genes11111275","article-title":"Genome-wide association study of metamizole-induced agranulocytosis in European populations","volume":"11","author":"Cismaru","year":"","journal-title":"Genes (Basel)"},{"key":"B10","volume-title":"Pharmacotherapy: a pathophysiologic approach","author":"DiPiro","year":"2023"},{"key":"B11","doi-asserted-by":"publisher","first-page":"8515","DOI":"10.1007\/s00210-024-03240-2","article-title":"Safety of metamizole (dipyrone) for the treatment of mild to moderate Pain\u2014an overview of systematic reviews","volume":"397","author":"Eleut\u00e9rio","year":"2024","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B12","first-page":"1","article-title":"Assessment report metamizole-containing medicinal products","volume":"31","year":"2019","journal-title":"Eur. Med. Agency (EMA)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3186328","DOI":"10.1155\/2017\/3186328","article-title":"HLA association with drug-induced adverse reactions","volume":"2017","author":"Fan","year":"2017","journal-title":"J. Immunol. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"D1503","DOI":"10.1093\/nar\/gkad1017","article-title":"Withdrawn 2.0\u2014update on withdrawn drugs with pharmacovigilance data","volume":"52","author":"Gallo","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1182\/blood-2014-02-482612","article-title":"How we evaluate and treat neutropenia in adults","volume":"124","author":"Gibson","year":"2014","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.15202\/10.15202\/1981896.2021v27n54p96","article-title":"POL\u00cdTICA DE PROIBI\u00c7\u00c3O DA DIPIRONA","volume":"27","author":"Guimar\u00e3es","year":"2021","journal-title":"Rev. Augustus"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0138237","DOI":"10.1371\/journal.pone.0138237","article-title":"The role of Google scholar in evidence reviews and its applicability to grey Literature searching","volume":"10","author":"Haddaway","year":"2015","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e29518","DOI":"10.7759\/cureus.29518","article-title":"Overview of methotrexate toxicity: a comprehensive literature review","volume":"14","author":"Hamed","year":"2022","journal-title":"Cureus"},{"key":"B19","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00228-008-0513-7","article-title":"Incidence and risk factors for agranulocytosis in Latin American countries--the Latin study: a multicenter study","volume":"64","author":"Hamerschlak","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00228-014-1777-8","article-title":"Metamizole-induced agranulocytosis revisited: results from the prospective Berlin case\u2013control surveillance study","volume":"71","author":"Huber","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00228-004-0836-y","article-title":"Agranulocytosis associated with dipyrone (metamizol)","volume":"60","author":"Ib\u00e1\u00f1ez","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1517\/17425255.2015.985649","article-title":"Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis","volume":"11","author":"Johnston","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41398-021-01322-w","article-title":"HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry","volume":"11","author":"Konte","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0122918","DOI":"10.1371\/journal.pone.0122918","article-title":"Metamizole-associated adverse events: a systematic review and meta-analysis","volume":"10","author":"K\u00f6tter","year":"2015","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/jcph.1512","article-title":"Metamizole (dipyrone) and the liver: a review of the literature","volume":"59","author":"Lutz","year":"2019","journal-title":"J. Clin. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00228-024-03706-5","article-title":"Risk of agranulocytosis with metamizole in comparison with alternative medications based on health records in Spain","volume":"80","author":"Maci\u00e1-Mart\u00ednez","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1177\/147323000203000504","article-title":"The incidence of metamizole sodium-induced agranulocytosis in Poland","volume":"30","author":"Maj","year":"2002","journal-title":"J. Int. Med. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/02537176221103617","article-title":"Bibliometric analysis for medical research","volume":"45","author":"Manoj Kumar","year":"2023","journal-title":"Indian J. Psychol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/tan.15035","article-title":"Genomic characterization of HLA class I and class II genes in ethnically diverse sub-saharan African populations: a report on novel HLA alleles","volume":"102","author":"Pagkrati","year":"2023","journal-title":"HLA"},{"key":"B31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/FPC.0000000000000432","article-title":"NAT2 polymorphisms as a cause of metamizole-induced agranulocytosis","volume":"31","author":"Radulovic","year":"2021","journal-title":"Pharmacogenet Genomics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bcp.2019.01.011","article-title":"Non-immunological toxicological mechanisms of metamizole-associated neutropenia in HL60 cells","volume":"163","author":"Rudin","year":"","journal-title":"Biochem. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"152254","DOI":"10.1016\/j.tox.2019.152254","article-title":"Toxicity of metamizole on differentiating HL60 cells and human neutrophil granulocytes","volume":"426","author":"Rudin","year":"","journal-title":"Toxicology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/exd.13256","article-title":"SVEP1 plays a crucial role in epidermal differentiation","volume":"26","author":"Samuelov","year":"2017","journal-title":"Exp. Dermatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/jcpt.12768","article-title":"Metamizole (dipyrone)-induced agranulocytosis: does the risk vary according to ethnicity?","volume":"44","author":"Shah","year":"2019","journal-title":"J. Clin. Pharm. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/archinte.159.4.369","article-title":"A population-based case-cohort study of drug-associated agranulocytosis","volume":"159","author":"van der Klauw","year":"1999","journal-title":"Arch. Intern Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00008571-199602000-00005","article-title":"Genetic factors and risk of agranulocytosis from metamizol","volume":"6","author":"Vlahov","year":"1996","journal-title":"Pharmacogenetics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2217\/pme-2018-0089","article-title":"Current applications of precision medicine: a bibliometric analysis","volume":"16","author":"Williams","year":"2019","journal-title":"Per Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.neo.2020.03.001","article-title":"MKL1\/miR-5100\/CAAP1 loop regulates autophagy and apoptosis in gastric cancer cells","volume":"22","author":"Zhang","year":"2020","journal-title":"Neoplasia"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1624044\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T07:22:29Z","timestamp":1758698549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1624044\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":40,"alternative-id":["10.3389\/fphar.2025.1624044"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1624044","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"article-number":"1624044"}}